Rowland Thomas Andrew, SVP and Head of Established Brands at ANI Pharmaceuticals Inc. ($ANIP), made two open market sales of company stock over the last year, totaling $784 thousand. His latest sale occurred on March 11, 2026. These transactions rank him 5,458th among 11,678 insiders by sale value, well below the average of 8.6 million dollars per insider across about 6.4 trades. He reported no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 11, 2026 | ANI PHARMACEUTICALS INC | $ANIP | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | S | Common Stock | 4772 | $74.91 | 38,730.0000 | 23,076,000 | 10.97% | 0.02% |
| Feb. 28, 2026 | ANI PHARMACEUTICALS INC | $ANIP | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | F | Common Stock | 628 | $73.90 | 43,502.0000 | 23,076,000 | 1.42% | 0.00% |
| Feb. 26, 2026 | ANI PHARMACEUTICALS INC | $ANIP | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | A | Common Stock | 6021 | $77.15 | 44,130.0000 | 23,076,000 | 15.80% | 0.03% |
| Feb. 12, 2026 | ANI PHARMACEUTICALS INC | $ANIP | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | F | Common Stock | 566 | $76.70 | 38,594.0000 | 23,076,000 | 1.45% | 0.00% |
| Feb. 14, 2026 | ANI PHARMACEUTICALS INC | $ANIP | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | F | Common Stock | 485 | $77.36 | 38,109.0000 | 23,076,000 | 1.26% | 0.00% |
| Feb. 11, 2026 | ANI PHARMACEUTICALS INC | $ANIP | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | F | Common Stock | 1762 | $76.25 | 39,160.0000 | 23,076,000 | 4.31% | 0.01% |
| Aug. 12, 2025 | ANI PHARMACEUTICALS INC | $ANIP | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | S | Common Stock | 4975 | $85.71 | 40,794.0000 | 22,322,000 | 10.87% | 0.02% |
| Feb. 28, 2025 | ANI PHARMACEUTICALS INC | $ANIP | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | F | Common Stock | 627 | $61.89 | 45,465.0000 | 21,538,000 | 1.36% | 0.00% |
| Feb. 14, 2025 | ANI PHARMACEUTICALS INC | $ANIP | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | F | Common Stock | 582 | $58.92 | 46,092.0000 | 21,538,000 | 1.25% | 0.00% |
| Feb. 12, 2025 | ANI PHARMACEUTICALS INC | $ANIP | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | A | Common Stock | 5222 | $0.00 | 46,674.0000 | 21,538,000 | 12.60% | 0.02% |
| Feb. 12, 2025 | ANI PHARMACEUTICALS INC | $ANIP | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | A | Common Stock | 7834 | $0.00 | 41,452.0000 | 21,538,000 | 23.30% | 0.04% |
| Nov. 15, 2024 | ANI PHARMACEUTICALS INC | $ANIP | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | F | Common Stock | 867 | $56.58 | 33,169.0000 | 21,494,000 | 2.55% | 0.00% |